Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory tofluoropyrimidine-and platinum-based chemotherapy (OGSG1201)
国際学会発表
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus platinum (OGSG0701)
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP(OGSG0701)
A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group(OGSG1205)
A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer ; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer ; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of new combination regimen with trastuzumab, S-1 and CDDP in HER2- positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of Trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study(HERBIS-1 trial)
Multicenter phase II study of triplet combination chemotherapy with paclitaxel, cisplatin, and S-1 for advanced gastric cancer (OGSG0703)
A Randomized Controlled Phase III Trial to Evaluate the Effect of Preoperative Enteral Immunonutrition on the Surgical Site Infection after Total Gastrectomy (OGSG0507)